High-dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes.

Abstract

BACKGROUND Docosahexaenoic acid (DHA) has been associated with downregulation of inflammatory responses. OBJECTIVE To report the effect of DHA supplementation on long-term atopic and respiratory outcomes in preterm infants. METHODS This study is a multicenter, randomized controlled trial comparing the outcomes for preterm infants <33 weeks' gestation… (More)
DOI: 10.1542/peds.2010-2405

Topics

3 Figures and Tables

Slides referencing similar topics